Oxidative stress sensitivity in ALS muscle cells

Experimental Neurology

Volumn 220, Issue 2, 2009, Pages 219-223

  Dupuis, Luc ^a,b  

^a INSERM   (France)

^b UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENIN; ANTIOXIDANT; COPPER ZINC SUPEROXIDE DISMUTASE; DYNACTIN; MITOCHONDRIAL DNA; PARAQUAT; PROTEIN NOGO A; RNA BINDING PROTEIN; SYNAPTOBREVIN; TAR DNA BINDING PROTEIN;

AMYOTROPHIC LATERAL SCLEROSIS; ANTIOXIDANT ACTIVITY; ARTICLE; ASTROCYTOSIS; CELL DEATH; CELL STRESS; DISEASE MODEL; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DRUG RESEARCH; GENE DELETION; GENE MUTATION; GLIA CELL; HUMAN; MOTONEURON; MUSCLE ATROPHY; MUSCLE CELL; MUSCLE DENERVATION; NERVE DEGENERATION; NEUROMUSCULAR SYNAPSE; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SKELETAL MUSCLE;

AMYOTROPHIC LATERAL SCLEROSIS; HUMANS; MITOCHONDRIA, MUSCLE; MITOCHONDRIAL MYOPATHIES; MUSCLE FIBERS, SKELETAL; MUSCLE, SKELETAL; MYOBLASTS; OXIDATIVE STRESS;

EID: 71549164101     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2009.08.023     Document Type: Note

References (57)

1. Afifi A.K., Aleu F.P., Goodgold J., and MacKay B. Ultrastructure of atrophic muscle in amyotrophic lateral sclerosis. Neurology 16 (1966) 475-481
2. Bergemalm D., Jonsson P.A., Graffmo K.S., Andersen P.M., Brannstrom T., Rehnmark A., and Marklund S.L. Overloading of stable and exclusion of unstable human superoxide dismutase-1 variants in mitochondria of murine amyotrophic lateral sclerosis models. J. Neurosci. 26 (2006) 4147-4154
3. Boillee S., Vande Velde C., and Cleveland D.W. ALS: a disease of motor neurons and their nonneuronal neighbors. Neuron 52 (2006) 39-59
4. Boillee S., Yamanaka K., Lobsiger C.S., Copeland N.G., Jenkins N.A., Kassiotis G., Kollias G., and Cleveland D.W. Onset and progression in inherited ALS determined by motor neurons and microglia. Science 312 (2006) 1389-1392
5. Borthwick G.M., Taylor R.W., Walls T.J., Tonska K., Taylor G.A., Shaw P.J., Ince P.G., and Turnbull D.M. Motor neuron disease in a patient with a mitochondrial tRNAIle mutation. Ann. Neurol. 59 (2006) 570-574
6. Bradley L.J., Taanman J.W., Kallis C., and Orrell R.W. Increased sensitivity of myoblasts to oxidative stress in amyotrophic lateral sclerosis peripheral tissues. Exp. Neurol. 218 (2009) 92-97
7. Bruijn L.I., Becher M.W., Lee M.K., Anderson K.L., Jenkins N.A., Copeland N.G., Sisodia S.S., Rothstein J.D., Borchelt D.R., Price D.L., and Cleveland D.W. ALS-linked SOD1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions. Neuron 18 (1997) 327-338
8. Clement A.M., Nguyen M.D., Roberts E.A., Garcia M.L., Boillee S., Rule M., McMahon A.P., Doucette W., Siwek D., Ferrante R.J., Brown Jr. R.H., Julien J.P., Goldstein L.S., and Cleveland D.W. Wild-type nonneuronal cells extend survival of SOD1 mutant motor neurons in ALS mice. Science 302 (2003) 113-117
9. Comi G.P., Bordoni A., Salani S., Franceschina L., Sciacco M., Prelle A., Fortunato F., Zeviani M., Napoli L., Bresolin N., Moggio M., Ausenda C.D., Taanman J.W., and Scarlato G. Cytochrome c oxidase subunit I microdeletion in a patient with motor neuron disease. Ann. Neurol. 43 (1998) 110-116
10. Corti S., Donadoni C., Ronchi D., Bordoni A., Fortunato F., Santoro D., Del Bo R., Lucchini V., Crugnola V., Papadimitriou D., Salani S., Moggio M., Bresolin N., and Comi G.P. Amyotrophic lateral sclerosis linked to a novel SOD1 mutation with muscle mitochondrial dysfunction. J. Neurol. Sci. 276 (2009) 170-174
11. Curti D., Malaspina A., Facchetti G., Camana C., Mazzini L., Tosca P., Zerbi F., and Ceroni M. Amyotrophic lateral sclerosis: oxidative energy metabolism and calcium homeostasis in peripheral blood lymphocytes. Neurology 47 (1996) 1060-1064
12. Deforges S., Branchu J., Biondi O., Clement G., Pariset C., Lecolle S., Lopes P., Vidal P.P., Chanoine C., and Charbonnier F. Motor neuron survival is promoted by specific exercise in a mouse model of amyotrophic-lateral-sclerosis. J. Physiol. 587 Pt 14 (2009) 3561-3572
13. Dewil M., dela Cruz V.F., Van Den Bosch L., and Robberecht W. Inhibition of p38 mitogen activated protein kinase activation and mutant SOD1(G93A)-induced motor neuron death. Neurobiol. Dis. 26 (2007) 332-341
14. Dobrowolny G., Giacinti C., Pelosi L., Nicoletti C., Winn N., Barberi L., Molinaro M., Rosenthal N., and Musaro A. Muscle expression of a local Igf-1 isoform protects motor neurons in an ALS mouse model. J. Cell. Biol. 168 (2005) 193-199
15. Dobrowolny G., Aucello M., Rizzuto E., Beccafico S., Mammucari C., Bonconpagni S., Belia S., Wannenes F., Nicoletti C., Del Prete Z., Rosenthal N., Molinaro M., Protasi F., Fano G., Sandri M., and Musaro A. Skeletal muscle is a primary target of SOD1G93A-mediated toxicity. Cell. Metab. 8 (2008) 425-436
16. Dupuis L., and Loeffler J.P. Neuromuscular junction destruction during amyotrophic lateral sclerosis: insights from transgenic models. Curr. Opin. Pharmacol. 9 (2009) 341-346
17. Dupuis L., Gonzalez de Aguilar J.L., di Scala F., Rene F., de Tapia M., Pradat P.F., Lacomblez L., Seihlan D., Prinjha R., Walsh F.S., Meininger V., and Loeffler J.P. Nogo provides a molecular marker for diagnosis of amyotrophic lateral sclerosis. Neurobiol. Dis. 10 (2002) 358-365
18. Dupuis L., di Scala F., Rene F., de Tapia M., Oudart H., Pradat P.F., Meininger V., and Loeffler J.P. Up-regulation of mitochondrial uncoupling protein 3 reveals an early muscular metabolic defect in amyotrophic lateral sclerosis. FASEB J. 17 (2003) 2091-2093
19. Dupuis L., Gonzalez de Aguilar J.L., Oudart H., de Tapia M., Barbeito L., and Loeffler J.P. Mitochondria in amyotrophic lateral sclerosis: a trigger and a target. Neurodegener. Dis. 1 (2004) 245-254
20. Dupuis L., Oudart H., Rene F., Gonzalez de Aguilar J.L., and Loeffler J.P. Evidence for defective energy homeostasis in amyotrophic lateral sclerosis: benefit of a high-energy diet in a transgenic mouse model. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 11159-11164
21. Dupuis L., Gonzalez de Aguilar J.L., Echaniz-Laguna A., Eschbach J., Rene F., Oudart H., Halter B., Huze C., Schaeffer L., Bouillaud F., and Loeffler J.P. Muscle mitochondrial uncoupling dismantles neuromuscular junction and triggers distal degeneration of motor neurons. PLoS One 4 (2009) e5390
22. Echaniz-Laguna A., Zoll J., Ribera F., Tranchant C., Warter J.M., Lonsdorfer J., and Lampert E. Mitochondrial respiratory chain function in skeletal muscle of ALS patients. Ann. Neurol. 52 (2002) 623-627
23. Echaniz-Laguna A., Zoll J., Ponsot E., N'Guessan B., Tranchant C., Loeffler J.P., and Lampert E. Muscular mitochondrial function in amyotrophic lateral sclerosis is progressively altered as the disease develops: a temporal study in man. Exp. Neurol. 198 (2006) 25-30
24. Feissner R.F., Skalska J., Gaum W.E., and Sheu S.S. Crosstalk signaling between mitochondrial Ca2+ and ROS. Front. Biosci. 14 (2009) 1197-1218
25. Finsterer J. Mitochondriopathy as a differential diagnosis of amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. Other Motor Neuron. Disord. 3 (2002) 219-224
26. Finsterer J. Mitochondriopathy mimicking amyotrophic lateral sclerosis. Neurologist 9 (2003) 45-48
27. Finsterer J. Lactate stress testing in sporadic amyotrophic lateral sclerosis. Int. J. Neurosci. 115 (2005) 583-591
28. Fischer L.R., Culver D.G., Tennant P., Davis A.A., Wang M., Castellano-Sanchez A., Khan J., Polak M.A., and Glass J.D. Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man. Exp. Neurol. 185 (2004) 232-240
29. Gonzalez de Aguilar J.L., Echaniz-Laguna A., Fergani A., Rene F., Meininger V., Loeffler J.P., and Dupuis L. Amyotrophic lateral sclerosis: all roads lead to Rome. J. Neurochem. 101 5 (2007) 1153-1160
30. Gould T.W., Buss R.R., Vinsant S., Prevette D., Sun W., Knudson C.M., Milligan C.E., and Oppenheim R.W. Complete dissociation of motor neuron death from motor dysfunction by Bax deletion in a mouse model of ALS. J. Neurosci. 26 (2006) 8774-8786
31. Grehl T., Fischer S., Muller K., Malin J.P., and Zange J. A prospective study to evaluate the impact of 31P-MRS to determinate mitochondrial dysfunction in skeletal muscle of ALS patients. Amyotroph. Lateral Scler. 8 (2007) 4-8
32. Hirano M., Angelini C., Montagna P., Hays A.P., Tanji K., Mitsumoto H., Gordon P.H., Naini A.B., DiMauro S., and Rowland L.P. Amyotrophic lateral sclerosis with ragged-red fibers. Arch. Neurol. 65 (2008) 403-406
33. Jaiswal M.K., and Keller B.U. Cu/Zn superoxide dismutase typical for familial amyotrophic lateral sclerosis increases the vulnerability of mitochondria and perturbs Ca2+ homeostasis in SOD1G93A mice. Mol. Pharmacol. 75 (2009) 478-489
34. Jokic N., Gonzalez de Aguilar J.L., Dimou L., Lin S., Fergani A., Ruegg M.A., Schwab M.E., Dupuis L., and Loeffler J.P. The neurite outgrowth inhibitor Nogo-A promotes denervation in an amyotrophic lateral sclerosis model. EMBO Rep. 7 (2006) 1162-1167
35. Kaspar B.K., Frost L.M., Christian L., Umapathi P., and Gage F.H. Synergy of insulin-like growth factor-1 and exercise in amyotrophic lateral sclerosis. Ann. Neurol. 57 (2005) 649-655
36. Kirkinezos I.G., Hernandez D., Bradley W.G., and Moraes C.T. Regular exercise is beneficial to a mouse model of amyotrophic lateral sclerosis. Ann. Neurol. 53 (2003) 804-807
37. Klivenyi P., Ferrante R.J., Matthews R.T., Bogdanov M.B., Klein A.M., Andreassen O.A., Mueller G., Wermer M., Kaddurah-Daouk R., and Beal M.F. Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis. Nat. Med. 5 (1999) 347-350
38. Krasnianski A., Deschauer M., Neudecker S., Gellerich F.N., Muller T., Schoser B.G., Krasnianski M., and Zierz S. Mitochondrial changes in skeletal muscle in amyotrophic lateral sclerosis and other neurogenic atrophies. Brain 128 (2005) 1870-1876
39. Mattiazzi M., D'Aurelio M., Gajewski C.D., Martushova K., Kiaei M., Beal M.F., and Manfredi G. Mutated human SOD1 causes dysfunction of oxidative phosphorylation in mitochondria of transgenic mice. J. Biol. Chem. 277 (2002) 29626-29633
40. Morrison B.M., Gordon J.W., Ripps M.E., and Morrison J.H. Quantitative immunocytochemical analysis of the spinal cord in G86R superoxide dismutase transgenic mice: neurochemical correlates of selective vulnerability. J. Comp. Neurol. 373 (1996) 619-631
41. Nguyen K.T., Garcia-Chacon L.E., Barrett J.N., Barrett E.F., and David G. The Psi(m) depolarization that accompanies mitochondrial Ca2+ uptake is greater in mutant SOD1 than in wild-type mouse motor terminals. Proc. Natl. Acad. Sci. U. S. A. 106 (2009) 2007-2011
42. Nicholls D.G. Oxidative stress and energy crises in neuronal dysfunction. Ann. N.Y. Acad. Sci. 1147 (2008) 53-60
43. Orrell R.W., Lane R.J., and Ross M. A systematic review of antioxidant treatment for amyotrophic lateral sclerosis/motor neuron disease. Amyotroph. Lateral Scler. 9 (2008) 195-211
44. Peled-Kamar M., Lotem J., Wirguin I., Weiner L., Hermalin A., and Groner Y. Oxidative stress mediates impairment of muscle function in transgenic mice with elevated level of wild-type Cu/Zn superoxide dismutase. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 3883-3887
45. Pradat P.F., Bruneteau G., Gonzalez de Aguilar J.L., Dupuis L., Jokic N., Salachas F., Le Forestier N., Echaniz-Laguna A., Dubourg O., Hauw J.J., Tranchant C., Loeffler J.P., and Meininger V. Muscle Nogo-A expression is a prognostic marker in lower motor neuron syndromes. Ann. Neurol. 62 (2007) 15-20
46. Ripps M.E., Huntley G.W., Hof P.R., Morrison J.H., and Gordon J.W. Transgenic mice expressing an altered murine superoxide dismutase gene provide an animal model of amyotrophic lateral sclerosis. Proc. Natl. Acad. Sci. U. S. A. 92 (1995) 689-693
47. Ro L.S., Lai S.L., Chen C.M., and Chen S.T. Deleted 4977-bp mitochondrial DNA mutation is associated with sporadic amyotrophic lateral sclerosis: a hospital-based case-control study. Muscle Nerve 28 (2003) 737-743
48. Rouaux C., Panteleeva I., Rene F., Gonzalez de Aguilar J.L., Echaniz-Laguna A., Dupuis L., Menger Y., Boutillier A.L., and Loeffler J.P. Sodium valproate exerts neuroprotective effects in vivo through CREB-binding protein-dependent mechanisms but does not improve survival in an amyotrophic lateral sclerosis mouse model. J. Neurosci. 27 (2007) 5535-5545
49. Sasaki S., and Iwata M. Mitochondrial alterations in the spinal cord of patients with sporadic amyotrophic lateral sclerosis. J. Neuropathol. Exp. Neurol. 66 (2007) 10-16
50. Siciliano G., Pastorini E., Pasquali L., Manca M.L., Iudice A., and Murri L. Impaired oxidative metabolism in exercising muscle from ALS patients. J. Neurol. Sci. 191 (2001) 61-65
51. Siciliano G., D'Avino C., Del Corona A., Barsacchi R., Kusmic C., Rocchi A., Pastorini E., and Murri L. Impaired oxidative metabolism and lipid peroxidation in exercising muscle from ALS patients. Amyotroph. Lateral Scler. Other Motor Neuron. Disord. 3 (2002) 57-62
52. Veldink J.H., Bar P.R., Joosten E.A., Otten M., Wokke J.H., and van den Berg L.H. Sexual differences in onset of disease and response to exercise in a transgenic model of ALS. Neuromuscul. Disord. 13 (2003) 737-743
53. Vielhaber S., Winkler K., Kirches E., Kunz D., Buchner M., Feistner H., Elger C.E., Ludolph A.C., Riepe M.W., and Kunz W.S. Visualization of defective mitochondrial function in skeletal muscle fibers of patients with sporadic amyotrophic lateral sclerosis. J. Neurol. Sci. 169 (1999) 133-139
54. Vielhaber S., Kunz D., Winkler K., Wiedemann F.R., Kirches E., Feistner H., Heinze H.J., Elger C.E., Schubert W., and Kunz W.S. Mitochondrial DNA abnormalities in skeletal muscle of patients with sporadic amyotrophic lateral sclerosis. Brain 123 Pt. 7 (2000) 1339-1348
55. Wiedemann F.R., Winkler K., Kuznetsov A.V., Bartels C., Vielhaber S., Feistner H., and Kunz W.S. Impairment of mitochondrial function in skeletal muscle of patients with amyotrophic lateral sclerosis. J. Neurol. Sci. 156 (1998) 65-72
56. Wong P.C., Pardo C.A., Borchelt D.R., Lee M.K., Copeland N.G., Jenkins N.A., Sisodia S.S., Cleveland D.W., and Price D.L. An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria. Neuron 14 (1995) 1105-1116
57. Yamanaka K., Chun S.J., Boillee S., Fujimori-Tonou N., Yamashita H., Gutmann D.H., Takahashi R., Misawa H., and Cleveland D.W. Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis. Nat. Neurosci. 11 3 (2008) 251-253